Accelerating biomedical innovation through AI-enabled bioimage analysis.
Micrographia Bio is a next-generation drug-discovery company, operating at the intersection of ML, Engineering, and Biology. Traditional pharma asks, “Which of these thousands of compounds will cure this target disease?”. We ask, “Which disease is this compound best suited to cure?”
Our technology is 80% ML, 20% cell biology (and 100% “astounding” according to our seven pilot partnerships). Our tech allows us to map each chemical we test to its true activities inside human cells. By aggregating each chemical activity map, we are building an atlas for modern drug discovery.